Schedule 13G ownership disclosure
Akers Biosciences, Inc.
Security class unavailable · CUSIP: 00973E409
Event date: 2020-11-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-20-038462
- Form type
- SC 13G
- Filer
- Q/C TECHNOLOGIES, INC.
- CIK
- CIK 1321834
- Filed
- Nov 20, 2020
- Reporting period
- Nov 17, 2020
- Description
- Schedule 13G beneficial ownership